Wednesday, February 21, 2018

British Journal of Cancer - Table of Contents alert Volume 118 Issue 4

If you are unable to see the message below, click here to view.
British Journal of Cancer

Volume 118, Issue 4 (April 2018)

In this issue
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Cellular & Molecular Biology
Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed


Protein kinase D1: gatekeeper of the epithelial phenotype and key regulator of cancer metastasis?

Peter Storz

British Journal of Cancer 2018 118 :459 - 461; February 20, 2018; 10.1038/bjc.2018.1


Abstract | Full Text

Clinical Studies

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

R D Kim, S R Alberts, C Peña, I Genvresse, A Ajavon-Hartmann et al.

British Journal of Cancer 2018 118 :462 - 470; January 18, 2018; 10.1038/bjc.2017.428


Abstract | Full Text

Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota

James J Goedert, Xing Hua, Agata Bielecka, Isao Okayasu, Ginger L Milne et al.

British Journal of Cancer 2018 118 :471 - 479; January 23, 2018; 10.1038/bjc.2017.435


Abstract | Full Text

Immune gene expression and response to chemotherapy in advanced breast cancer

Theodoros Foukakis, John Lövrot, Alexios Matikas, Ioannis Zerdes, Julie Lorent et al.

British Journal of Cancer 2018 118 :480 - 488; January 25, 2018; 10.1038/bjc.2017.446


Abstract | Full Text

Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England

Julie Nossiter, Arunan Sujenthiran, Susan C Charman, Paul J Cathcart, Ajay Aggarwal et al.

British Journal of Cancer 2018 118 :489 - 494; January 18, 2018; 10.1038/bjc.2017.454


Abstract | Full Text

Translational Therapeutics

Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma

Chiao-En Wu, Arman Esfandiari, Yi-Hsuan Ho, Nan Wang, Ahmed Khairallah Mahdi et al.

British Journal of Cancer 2017 118 :495 - 508; December 12, 2017; 10.1038/bjc.2017.433


Abstract | Full Text

Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma

Hailong Ma, Shufang Jin, Wenyi Yang, Ge Zhou, Mei Zhao et al.

British Journal of Cancer 2018 118 :509 - 521; January 18, 2018; 10.1038/bjc.2017.442


Abstract | Full Text

H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma

Wenyan Zhang, Rui Duan, Jian Zhang, William K C Cheung, Xiaoge Gao et al.

British Journal of Cancer 2018 118 :522 - 533; January 18, 2018; 10.1038/bjc.2017.461


Abstract | Full Text

A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy

Hyun-Il Cho, Un-Hee Kim, A-Ri Shin, Ji-Na Won, Hyun-Joo Lee et al.

British Journal of Cancer 2018 118 :534 - 545; January 23, 2018; 10.1038/bjc.2017.475


Abstract | Full Text

Molecular Diagnostics

Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma

Carole Siret, Aurélie Dobric, Anna Martirosyan, Chloé Terciolo, Sébastien Germain et al.

British Journal of Cancer 2017 118 :546 - 557; November 21, 2017; 10.1038/bjc.2017.411


Abstract | Full Text

LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity

R G Morgan, E Mortensson, D N Legge, B Gupta, T J Collard et al.

British Journal of Cancer 2017 118 :558 - 565; November 16, 2017; 10.1038/bjc.2017.412


Abstract | Full Text

Inflammatory cytokine IL-8/CXCL8 promotes tumour escape from hepatocyte-induced dormancy

Ahmad S Khazali, Amanda M Clark & Alan Wells

British Journal of Cancer 2017 118 :566 - 576; November 23, 2017; 10.1038/bjc.2017.414


Abstract | Full Text

Tumour budding in oral squamous cell carcinoma: a meta-analysis

Alhadi Almangush, Matti Pirinen, Ilkka Heikkinen, Antti A Mäkitie, Tuula Salo et al.

British Journal of Cancer 2017 118 :577 - 586; November 30, 2017; 10.1038/bjc.2017.425


Abstract | Full Text

Cellular & Molecular Biology

Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1

Aditya Ganju, Subhash C Chauhan, Bilal Bin Hafeez, Kyle Doxtater, Manish K Tripathi et al.

British Journal of Cancer 2018 118 :587 - 599; February 20, 2018; 10.1038/bjc.2017.431


Abstract | Full Text


Domestic light at night and breast cancer risk: a prospective analysis of 105?000 UK women in the Generations Study

Louise E Johns, Michael E Jones, Minouk J Schoemaker, Emily McFadden, Alan Ashworth et al.

British Journal of Cancer 2018 118 :600 - 606; January 23, 2018; 10.1038/bjc.2017.359


Abstract | Full Text

Anthropometric measurements and survival after a prostate cancer diagnosis


British Journal of Cancer 2017 118 :607 - 610; December 12, 2017; 10.1038/bjc.2017.440


Abstract | Full Text

Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study

Freija Verdoodt, Susanne K Kjaer, Christian Dehlendorff & Søren Friis

British Journal of Cancer 2018 118 :611 - 615; January 09, 2018; 10.1038/bjc.2017.449


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: